Fluicell AB is a provider of high resolution SINGLE-CELL DISCOVERY PLATFORMS for biomedicine, drug development, and bioprinting. The company's products include Biopen, Dynaflow.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.14 | $3.30 | $0.54 - $3.71 | $39.5M | 12M | 206K | -$0.20 |
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 11,580 | 6,091 | 2,789 | |
Revenue | 430 | 263 | 141 | 123 |
EBITDA | (1,840) | (1,920) | (1,661) | (862) |
Net Income | (1,938) | (1,970) | (1,689) | (874) |
Total Assets | 2,807 | 2,132 | 2,889 | 1,409 |
Total Debt | 0 | 535 | 0 | 9 |
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Fluicell‘s full profile, request access.
Request a free trialName | Representing | Role | Since |
---|---|---|---|
Aldo Jesroka | Fluicell | Scientific Advisor, Board Member & Co-Founder | 000 0000 |
Carl Fhager | Self | Board Member | 000 0000 |
Daniel Chiu | Fluicell | Board Member | 000 0000 |
Gavin Jeffries Ph.D | Fluicell | Chief Technology Officer, Board Member & Co-Founder | 000 0000 |
Owe Orwar | Self | Board Member | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial